AEMD
AETHLON MEDICAL INC
stockNASDAQ
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.05 | 2026-10-09 | -14.96% | 8.374 |
| 1M | 1.43 | 2026-09-16 | +259.79% | 47.762 |
| 3M | 3.35 | 2026-07-16 | +53.56% | 16.067 |
| 6M | 11.60 | 2026-04-16 | -55.65% | 7.524 |
| 1Y | 27.63 | 2025-10-16 | -81.38% | 4.452 |
| 2Y | 153.24 | 2024-10-16 | -96.64% | — |
| 5Y | 13,720.00 | 2021-10-15 | -99.96% | 1.315 |
AETHLON MEDICAL INC (NASDAQ:AEMD) stock price today is $5.15, and today's volume is 32,500. AEMD is down 2.372% today. The 30 day average volume is 3.32M. AEMD market cap is $3.66M with 711,136 shares outstanding.